indegeneWhite.main

Let’s partner for #FutureReadyHealthcare

newThemeh2

Unlock the potential of digitization to reimagine the regulatory affairs function

Regulatory Affairs Digital Council

newThemeh1

Establish a forum for industry leaders to discuss the adoption of digital tools across the global regulatory business, embrace functional transformation, and identify digital approaches for the future of regulatory affairs.

indegeneBlack.main

Mission

newThemeBody1

Support regulatory affairs organizations’ efforts to embrace innovation through data-driven, digital models to overcome contemporary challenges and shape the future of regulatory affairs.

Vision

What drives us

newThemeh3

The regulatory affairs digital council is a global forum for leaders in regulatory affairs to connect, learn, and share best practices as well as to help them modernize the regulatory affairs function to match the pace of the overall digital transformation of healthcare organizations.

Who we are

Back to Industry Councils

body1

VP, Head of Global Regulatory Policy & Innovation

primary.main

Andrew Robertson

newThemeBody12

Senior Vice President, Head of Regulatory Affairs

Charbel Haber

Global Head Regulatory Operations
                

David Berglund

Fillip Mussen

James Rawls

Jennifer Dudinak

Kim Quaintance-Lunn

Kristie Gauntt

Martine Zimmerman

Executive Director Regulatory Affairs Management & Digital Strategy

Michael O’Flynn

Natalie Tolli

Olivia Maurel

Senior Vice President, Regulatory Affairs

Paul Nitschmann

Raja Sekhar Vanga

IT Head, Strategic Business Partnering Regulatory & Medical

Sanjana Paranjpe

Scott Cleve

2.7rem

newThemeh4

Industry Survey on The HA Query Management Process​

newThemeh5

Bold New Vision for Pharma Legislation in the EU

Indegene Regulatory Capability

Resources

Manish Gupta

We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.

We are a digital-first, life sciences commercialization company

What we do

Establish a forum for industry leaders to discuss the adoption of digital tools across the global regulatory business, embrace functional transformation, and identify digital approaches for the future of regulatory affairs

Support regulatory affairs organizations’ efforts to embrace innovation through data-driven, digital models to overcome contemporary challenges and shape the future of regulatory affairs

Ask Indegene (Beta)

Hello, how can I help you today?

Thank you!

#FutureReadyHealthcare

Regulatory Affairs Digital Council

Who we are

Members

Andrew Robertson

VP, Head of Global Regulatory Policy & Innovation

Takeda

Charbel Haber

Senior Vice President, Head of Regulatory Affairs

Moderna

David Berglund

Global Head Regulatory Operations

AstraZeneca

Fillip Mussen

VP Regional Regulatory Affairs,

Janssen

James Rawls

Vice President, Regulatory Affairs

Sunovion Pharmaceuticals

Jennifer Dudinak

SVP, Global Regulatory Strategy & Policy

Bristol Myers Squibb

Kim Quaintance-Lunn

VP, US Regulatory Lead

Bayer

Kristie Gauntt

Head of J&J Regulatory Operations

Johnson & Johnson

Martine Zimmerman

Global Head Regulatory Affairs

Ipsen

Michael O’Flynn

Executive Director Regulatory Affairs Management & Digital Strategy

AstraZeneca

Natalie Tolli

VP, Regulatory Affairs,

AbbVie

Olivia Maurel

Head of Global Regulatory Affairs

Sobi

Paul Nitschmann

Senior Vice President, Regulatory Affairs

Intercept Pharmaceuticals

Raja Sekhar Vanga

VP, Global Regulatory Affairs,

Biocon

Sanjana Paranjpe

IT Head, Strategic Business Partnering Regulatory & Medical

Novartis

Scott Cleve

VP, Regulatory Operations and Compliance

Daiichi Sankyo